Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jun 13 04:00PM ET
10.17
Dollar change
0.00
Percentage change
0.00
%
IndexRUT P/E- EPS (ttm)-3.23 Insider Own5.96% Shs Outstand38.27M Perf Week0.00%
Market Cap389.24M Forward P/E- EPS next Y-1.57 Insider Trans100.42% Shs Float35.88M Perf Month33.82%
Income-130.81M PEG- EPS next Q-0.89 Inst Own116.81% Short Float7.06% Perf Quarter38.93%
Sales35.00M P/S11.12 EPS this Y15.74% Inst Trans32.01% Short Ratio2.06 Perf Half Y23.57%
Book/sh14.72 P/B0.69 EPS next Y44.03% ROA-20.30% Short Interest2.53M Perf Year-37.68%
Cash/sh13.60 P/C0.75 EPS next 5Y3.89% ROE-23.68% 52W Range4.80 - 18.13 Perf YTD32.42%
Dividend Est.- P/FCF- EPS past 5Y-34.39% ROIC-23.07% 52W High-43.91% Beta1.51
Dividend TTM- Quick Ratio14.13 Sales past 5Y- Gross Margin96.41% 52W Low111.87% ATR (14)0.40
Dividend Ex-Date- Current Ratio14.13 EPS Y/Y TTM14.60% Oper. Margin-435.19% RSI (14)71.85 Volatility1.05% 4.26%
Employees173 Debt/Eq0.01 Sales Y/Y TTM177.89% Profit Margin-373.75% Recom2.67 Target Price12.83
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q24.92% Payout- Rel Volume0.00 Prev Close10.17
Sales Surprise-100.00% EPS Surprise15.79% Sales Q/Q- EarningsApr 28 AMC Avg Volume1.23M Price10.17
SMA207.30% SMA5031.13% SMA20018.11% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
May-28-25Downgrade Wells Fargo Overweight → Equal Weight $12
May-28-25Downgrade Wedbush Outperform → Neutral $12
May-14-25Downgrade Leerink Partners Outperform → Market Perform $9
May-14-25Downgrade H.C. Wainwright Buy → Neutral
May-13-25Downgrade JP Morgan Overweight → Neutral
Aug-13-24Initiated Wells Fargo Overweight $31
May-05-21Initiated H.C. Wainwright Buy $37
Oct-08-20Initiated Robert W. Baird Outperform $45
Aug-18-20Initiated Wedbush Outperform $45
Aug-18-20Initiated SVB Leerink Outperform $45
May-30-25 12:00PM
May-29-25 07:59AM
May-28-25 08:30AM
08:10AM
May-15-25 07:55AM
06:00AM Loading…
May-14-25 06:00AM
May-13-25 12:35PM
07:55AM
07:10AM
May-02-25 09:55AM
Apr-28-25 04:30PM
Mar-25-25 04:35PM
Mar-13-25 09:55AM
Mar-05-25 07:00AM
Jan-13-25 12:00PM
07:00AM Loading…
Jan-10-25 07:00AM
Jan-08-25 07:00AM
Dec-20-24 07:20AM
Dec-13-24 01:25PM
Dec-12-24 08:55AM
Nov-26-24 07:00AM
Nov-12-24 07:00AM
Oct-24-24 07:00AM
Oct-16-24 01:01AM
Sep-30-24 01:01PM
Sep-16-24 04:04PM
Sep-15-24 09:12PM
Sep-14-24 08:10AM
02:30AM
Aug-28-24 04:30PM
08:30AM Loading…
Aug-20-24 08:30AM
Aug-08-24 08:20AM
07:00AM
Aug-05-24 07:00AM
Jul-09-24 12:33PM
Jul-08-24 07:00AM
Jun-18-24 06:33AM
Jun-17-24 09:00AM
May-13-24 08:28AM
May-10-24 01:53PM
12:21PM
09:40AM
08:26AM
08:24AM
08:09AM
Apr-07-24 04:30PM
Mar-06-24 02:51PM
07:01AM
07:00AM
Mar-05-24 04:30PM
Mar-01-24 07:00AM
Feb-26-24 06:11AM
Jan-08-24 07:00AM
Jan-03-24 07:00AM
Dec-13-23 09:55AM
Nov-27-23 09:55AM
Nov-21-23 07:00AM
Nov-13-23 09:55AM
Nov-10-23 09:55AM
Nov-07-23 07:00AM
Oct-31-23 03:01AM
Oct-16-23 01:46PM
04:38AM
Oct-11-23 05:55PM
Sep-06-23 07:00AM
Aug-26-23 11:02AM
Aug-24-23 11:30AM
Aug-23-23 04:10PM
02:00PM
09:24AM
Aug-08-23 07:00AM
Jun-21-23 08:00PM
May-13-23 08:03AM
May-11-23 06:11AM
May-10-23 08:35AM
07:01AM
May-05-23 08:51AM
Apr-26-23 08:00PM
Mar-23-23 01:56PM
Mar-21-23 06:07AM
Mar-17-23 06:18AM
Mar-15-23 08:35AM
07:00AM
Feb-28-23 07:00AM
Feb-07-23 01:51PM
07:00AM
Feb-02-23 02:19PM
Jan-09-23 07:00AM
Jan-03-23 07:00AM
Dec-07-22 08:07AM
Nov-22-22 07:00AM
Nov-10-22 07:55PM
04:01PM
Nov-04-22 05:46PM
Nov-02-22 10:00AM
Oct-18-22 08:36AM
Aug-12-22 06:16AM
Aug-10-22 05:25PM
04:01PM
Aug-02-22 07:00AM
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984. The company was founded by Michel Detheux in April 2012 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Detheux MichelChief Executive OfficerJun 10 '25Option Exercise4.30137,910593,01394,027Jun 11 09:01 PM
Detheux MichelChief Executive OfficerJun 09 '25Option Exercise4.3043,882188,69343,882Jun 11 09:01 PM
Detheux MichelChief Executive OfficerJun 10 '25Option Exercise4.3026,400113,520153,903Jun 11 09:01 PM
Detheux MichelChief Executive OfficerJun 09 '25Option Exercise4.308,40036,120144,303Jun 11 09:01 PM
Detheux MichelChief Executive OfficerJun 09 '25Sale10.0343,882440,1360Jun 11 09:01 PM
Detheux MichelChief Executive OfficerJun 10 '25Sale10.0243,883439,7080Jun 11 09:01 PM
Detheux MichelChief Executive OfficerJun 09 '25Sale10.038,40084,252135,903Jun 11 09:01 PM
Detheux MichelChief Executive OfficerJun 10 '25Sale10.028,40084,168135,903Jun 11 09:01 PM
Detheux MichelOfficerJun 10 '25Proposed Sale10.0252,283523,876Jun 10 04:19 PM
Detheux MichelOfficerJun 09 '25Proposed Sale10.1752,282531,708Jun 09 04:12 PM
Detheux MichelChief Executive OfficerJun 04 '25Option Exercise4.3043,883188,69743,883Jun 06 09:03 PM
Detheux MichelChief Executive OfficerJun 06 '25Option Exercise4.3043,882188,69343,882Jun 06 09:03 PM
Detheux MichelChief Executive OfficerJun 05 '25Option Exercise4.3043,882188,69343,882Jun 06 09:03 PM
Detheux MichelChief Executive OfficerJun 05 '25Option Exercise4.308,40036,120144,303Jun 06 09:03 PM
Detheux MichelChief Executive OfficerJun 04 '25Option Exercise4.308,40036,120144,303Jun 06 09:03 PM
Detheux MichelChief Executive OfficerJun 06 '25Option Exercise4.308,40036,120144,303Jun 06 09:03 PM
Detheux MichelChief Executive OfficerJun 06 '25Sale10.2143,882448,0350Jun 06 09:03 PM
Detheux MichelChief Executive OfficerJun 05 '25Sale10.1543,882445,4020Jun 06 09:03 PM
Detheux MichelChief Executive OfficerJun 04 '25Sale10.1043,883443,2180Jun 06 09:03 PM
Detheux MichelChief Executive OfficerJun 06 '25Sale10.218,40085,764135,903Jun 06 09:03 PM
Detheux MichelChief Executive OfficerJun 05 '25Sale10.158,40085,260135,903Jun 06 09:03 PM
Detheux MichelChief Executive OfficerJun 04 '25Sale10.108,40084,840135,903Jun 06 09:03 PM
Hallal DavidDirectorJun 06 '25Option Exercise4.3038,228164,38038,228Jun 06 09:03 PM
Hallal DavidDirectorJun 04 '25Option Exercise4.3038,227164,37638,227Jun 06 09:03 PM
Hallal DavidDirectorJun 05 '25Option Exercise4.3038,227164,37638,227Jun 06 09:03 PM
Hallal DavidDirectorJun 06 '25Sale10.2438,228391,4550Jun 06 09:03 PM
Hallal DavidDirectorJun 05 '25Sale10.1538,227388,0040Jun 06 09:03 PM
Hallal DavidDirectorJun 04 '25Sale10.0738,227384,9460Jun 06 09:03 PM
Detheux MichelOfficerJun 06 '25Proposed Sale10.1952,282532,754Jun 06 04:11 PM
DAVID L HALLALDirectorJun 06 '25Proposed Sale10.2438,228391,489Jun 06 04:09 PM
DAVID L HALLALDirectorJun 05 '25Proposed Sale10.1538,227388,103Jun 05 04:27 PM
Detheux MichelOfficerJun 05 '25Proposed Sale10.2252,282534,322Jun 05 04:10 PM
Detheux MichelOfficerJun 04 '25Proposed Sale10.0652,283525,967Jun 04 04:03 PM
DAVID L HALLALDirectorJun 04 '25Proposed Sale10.0738,227384,782Jun 04 04:03 PM
EcoR1 Capital, LLC10% OwnerMay 15 '25Buy8.003,300,00026,400,00010,688,978May 16 06:52 PM
EcoR1 Capital, LLC10% OwnerMay 14 '25Buy7.411,658,97812,285,5627,388,978May 16 06:52 PM
GADICKE ANSBERTFormer 10% OwnerMay 13 '25Sale8.061,031,9318,317,3643,452,797May 15 05:34 PM
MPM BIOVENTURES 2018, L.P.Former 10% OwnerMay 13 '25Sale8.06630,1915,079,3392,108,594May 15 05:33 PM
MPM BioVentures 2014, L.P.Former 10% OwnerMay 13 '25Sale8.06630,1915,079,3392,108,594May 15 05:32 PM
Van Hauwermeiren TimothyDirectorMay 13 '25Option Exercise4.3022,34696,08822,346May 14 08:00 PM
Gall MatthewChief Financial OfficerNov 19 '24Buy7.735,00038,63565,429Nov 19 07:59 PM